<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="07/03/13" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9199305" creator="Yumiko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9199305</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The immediate-early gene product <term sem="Protein_molecule" id="T1" lex="Egr-1">Egr-1</term> regulates the <term sem="DNA_domain_or_region" id="T2" lex="human_interleukin-2_receptor_beta-chain_promoter">human <term sem="DNA_domain_or_region" id="A4"><term sem="Protein_molecule" id="T3" lex="interleukin-2_receptor">interleukin-2 receptor</term> beta-chain promoter</term></term> through <cons sem="(AND DNA_domain_or_region DNA_domain_or_region)" id="T4" lex="(AND noncanonical_Egr_binding_site noncanonical_Sp1_binding_site)"><frag id="F1">noncanonical</frag> <frag id="F2"><term sem="DNA_domain_or_region" id="A1">Egr</term></frag> and <frag id="F3"><term sem="DNA_domain_or_region" id="A2">Sp1</term></frag> <frag id="F4"><term sem="DNA_domain_or_region" id="A3">binding sites</term></frag></cons>.</sentence>
<event id="E1">
<type class="Regulation" />
<theme idref1="A3" idref="A1" />
<cause idref="T1" />
<clue>The immediate-early gene product Egr-1 <clueType>regulates</clueType> the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites.</clue>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref1="A3" idref="A2" />
<cause idref="T1" />
<clue>The immediate-early gene product Egr-1 <clueType>regulates</clueType> the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites.</clue>
</event>
<event id="E3">
<type class="Regulation" />
<theme idref="A4" />
<cause idref="E1" />
<clue>The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter <linkCause>through</linkCause> noncanonical Egr and Sp1 binding sites.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E4">
<type class="Regulation" />
<theme idref="A4" />
<cause idref="E2" />
<clue>The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter <linkCause>through</linkCause> noncanonical Egr and Sp1 binding sites.</clue>
<comment>NO CLUETYPE</comment>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term sem="Protein_domain_or_region" id="T5" lex="interleukin-2_IL-2_receptor_beta-chain">interleukin-2 IL-2 receptor beta-chain</term> (<term sem="Protein_domain_or_region" id="T6" lex="IL-2Rbeta">IL-2Rbeta</term>) is an essential component of the <term sem="Protein_molecule" id="A5">receptors for</term> <term sem="Protein_molecule" id="T7" lex="IL-2">IL-2</term> and <term sem="Protein_molecule" id="T8" lex="IL-15">IL-15</term>.</sentence>
<sentence id="S3">Although <term sem="Protein_domain_or_region" id="T9" lex="IL-2Rbeta">IL-2Rbeta</term> is constitutively expressed by lymphocytes, its expression can be further induced by a number of stimuli, including <term sem="Organic_compound_other" id="T10" lex="phorbol_12-myristate_13-acetate">phorbol 12-myristate 13-acetate</term> (<term sem="Organic_compound_other" id="T11" lex="PMA">PMA</term>).</sentence>
<event id="E7">
<type class="Gene_expression" />
<theme idref="T9" />
<clue>Although IL-2Rbeta is constitutively <clueType>expressed</clueType> <clueLoc>by lymphocytes</clueLoc>, its expression can be further induced by a number of stimuli, including phorbol 12-myristate 13-acetate (PMA).</clue>
</event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="T11" />
<clue>Although IL-2Rbeta is constitutively expressed by lymphocytes, <corefTheme>its expression</corefTheme> can be further <clueType>induced</clueType> <linkCause>by</linkCause> <corefCause>a number of stimuli</corefCause>, including phorbol 12-myristate 13-acetate (PMA).</clue>
</event>
<sentence id="S4">We have now characterized <term sem="Protein_family_or_group" id="A7">factors</term> that bind to an <term sem="DNA_domain_or_region" id="A6">enhancer region located between <term sem="DNA_domain_or_region" id="T12" lex="nucleotides_-170_and_-139">nucleotides -170 and -139</term> of the human <term sem="DNA_domain_or_region" id="T13" lex="IL-2Rbeta_promoter"><term sem="Protein_molecule" id="T14" lex="IL-2Rbeta">IL-2Rbeta</term> promoter</term></term>.</sentence>
<event id="E9">
<type class="Binding" />
<theme idref="A7" />
<theme idref="A6" />
<clue>We have now characterized factors that <clueType>bind</clueType> <linkTheme>to</linkTheme> an enhancer region located between nucleotides -170 and -139 of the human IL-2Rbeta promoter.</clue>
<comment>TPS A6</comment>
</event>
<sentence id="S5">Both <term sem="Protein_molecule" id="T15" lex="Sp1">Sp1</term> and <term sem="Protein_molecule" id="T16" lex="Sp3">Sp3</term> bound to the <term sem="DNA_domain_or_region" id="T17" lex="5&apos;_portion">5&apos; portion</term> of this region, whereas a <term sem="Protein_family_or_group" id="T18" lex="PMA-inducible_factor"><term sem="Organic_compound_other" id="T19" lex="PMA">PMA</term>-inducible factor</term> (<term sem="Protein_family_or_group" id="T20" lex="PIF">PIF</term>) mainly bound to its <term sem="DNA_domain_or_region" id="T21" lex="3&apos;_portion">3&apos; portion</term> and bound to the <term sem="DNA_family_or_group" id="T22" lex="Sp_binding_motif">Sp binding motifs</term> as well.</sentence>
<event id="E10">
<type class="Binding" />
<theme idref="T15" />
<theme idref="T17" />
<clue>Both Sp1 and Sp3 <clueType>bound</clueType> <linkTheme>to</linkTheme> the 5&apos; portion of this region, whereas a PMA-inducible factor (PIF) mainly bound to its 3&apos; portion and bound to the Sp binding motifs as well.</clue>
</event>
<event id="E11">
<type class="Binding" />
<theme idref="T16" />
<theme idref="T17" />
<clue>Both Sp1 and Sp3 <clueType>bound</clueType> <linkTheme>to</linkTheme> the 5&apos; portion of this region, whereas a PMA-inducible factor (PIF) mainly bound to its 3&apos; portion and bound to the Sp binding motifs as well.</clue>
</event>
<event id="E12">
<type class="Binding" />
<theme idref="T20" />
<theme idref="T21" />
<clue>Both Sp1 and Sp3 bound to the 5&apos; portion of this region, whereas a PMA-inducible factor (PIF) mainly <clueType>bound</clueType> <linkTheme>to</linkTheme> its 3&apos; portion and bound to the Sp binding motifs as well.</clue>
</event>
<event id="E13">
<type class="Binding" />
<theme idref="T20" />
<theme idref="T22" />
<clue>Both Sp1 and Sp3 bound to the 5&apos; portion of this region, whereas a PMA-inducible factor (PIF) mainly bound to its 3&apos; portion and <clueType>bound</clueType> <linkTheme>to</linkTheme> the Sp binding motifs as well.</clue>
</event>
<sentence id="S6">In <term sem="Cell_cultured" id="T23" lex="Jurkat_T_cell">Jurkat <term sem="Cell_natural" id="T24" lex="T_cell">T cells</term></term>, induction of <term sem="Other" id="T25" lex="PIF_DNA_binding_activity"><term sem="Protein_family_or_group" id="T26" lex="PIF">PIF</term> <term sem="DNA_molecule" id="A8">DNA</term> binding activity</term> was rapidly induced, required de novo <term sem="Other" id="A9">protein synthesis</term>, and was sustained at a high level for at least 23 h.</sentence>
<event id="E14">
<type class="Binding" />
<theme idref="T26" />
<theme idref="A8" />
<clue>In Jurkat T cells, induction of PIF DNA <clueType>binding</clueType> activity was rapidly induced, required de novo protein synthesis, and was sustained at a high level for at least 23 h.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="E14" />
<clue>In Jurkat T cells, <clueType>induction</clueType> <linkTheme>of</linkTheme> PIF DNA binding activity was rapidly induced, required de novo protein synthesis, and was sustained at a high level for at least 23 h.</clue>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="E15" />
<clue><clueLoc>In Jurkat T cells</clueLoc>, induction of PIF DNA binding activity was <clueTime>rapidly</clueTime> <clueType>induced</clueType>, required de novo protein synthesis, and was sustained at a high level for at least 23 h.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="A9" />
<clue><clueLoc>In Jurkat T cells</clueLoc>, induction of PIF DNA binding activity was rapidly induced, <clueType>required</clueType> de novo protein synthesis, and was sustained at a high level for at least 23 h.</clue>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="E15" />
<clue><clueLoc>In Jurkat T cells</clueLoc>, induction of PIF DNA binding activity was rapidly induced, required de novo protein synthesis, and was <clueType>sustained</clueType> at a high level <clueTime>for at least 23 h</clueTime>.</clue>
</event>
<sentence id="S7">Interestingly, <term sem="Protein_family_or_group" id="T27" lex="PIF">PIF</term> was constitutively activated in <term sem="Cell_cultured" id="T28" lex="human_T-cell_leukemia_virus_type_1-transformed_MT-2_cell"><term sem="Virus" id="T29" lex="human_T-cell_leukemia_virus_type_1">human T-cell <term sem="Virus" id="A10">leukemia virus type 1</term></term>-transformed <term sem="Cell_natural" id="A11">MT-2 cells</term></term>.</sentence>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="T27" />
<clue>Interestingly, PIF was constitutively <clueType>activated</clueType> <clueLoc>in human T-cell leukemia virus type 1-transformed MT-2 cells</clueLoc>.</clue>
</event>
<event id="E20">
<type class="Biological_process" />
<theme idref="A11" />
<clue>Interestingly, PIF was constitutively activated in human T-cell leukemia virus type 1-<clueType>transformed</clueType> MT-2 cells.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="E20" />
<cause idref="T29" />
<clue>Interestingly, PIF was constitutively activated in human T-cell leukemia virus type 1-<clueType>transformed</clueType> MT-2 cells.</clue>
</event>
<sentence id="S8">In this paper, we demonstrate that <term sem="Protein_family_or_group" id="T30" lex="PIF">PIF</term> is <term sem="Protein_molecule" id="T31" lex="Egr-1">Egr-1</term> based on its recognition by <term sem="Protein_molecule" id="A12">anti-<term sem="Protein_molecule" id="T32" lex="Egr-1">Egr-1</term> antisera</term> in <term sem="Other" id="T33" lex="gel_mobility_shift_assay">gel mobility shift assays</term>, even though the <term sem="DNA_domain_or_region" id="T34" lex="IL-2Rbeta_DNA_binding_motif"><term sem="Protein_domain_or_region" id="T35" lex="IL-2Rbeta">IL-2Rbeta</term> DNA binding motif</term> differed substantially from the canonical <term sem="DNA_domain_or_region" id="T36" lex="Egr-1_binding_site"><term sem="Protein_molecule" id="T37" lex="Egr-1">Egr-1</term> binding site</term>.</sentence>
<event id="E21">
<type class="Binding" />
<theme idref="T30" />
<theme idref="A12" />
<clue>In this paper, we demonstrate that PIF is Egr-1 based on <corefTheme idref1="T30">its</corefTheme> <clueType>recognition</clueType> <linkTheme>by</linkTheme> anti-Egr-1 antisera <clueExperiment>in gel mobility shift assays</clueExperiment>, even though the IL-2Rbeta DNA binding motif differed substantially from the canonical Egr-1 binding site.</clue>
</event>
<sentence id="S9">In addition, <term sem="Protein_molecule" id="T38" lex="Egr-1">Egr-1</term> bound to the <term sem="DNA_domain_or_region" id="T39" lex="Sp_binding_site">Sp binding site</term>.</sentence>
<event id="E22">
<type class="Binding" />
<theme idref="T38" />
<theme idref="T39" />
<clue>In addition, Egr-1 <clueType>bound</clueType> <linkTheme>to</linkTheme> the Sp binding site.</clue>
</event>
<sentence id="S10">In <term sem="Cell_cultured" id="T40" lex="Jurkat_cell">Jurkat cells</term>, both sites were required for maximal <term sem="Other" id="T41" lex="IL-2Rbeta_promoter_activity"><term sem="DNA_domain_or_region" id="A13"><term sem="Protein_domain_or_region" id="T42" lex="IL-2Rbeta">IL-2Rbeta</term> promoter</term> activity</term>, and in <term sem="Cell_natural" id="A14">HeLaS3 cells</term>, transfection of <term sem="Protein_molecule" id="T43" lex="Egr-1">Egr-1</term> could drive activity of a <term sem="DNA_domain_or_region" id="A15">reporter construct</term> containing both sites.</sentence>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="A13" />
<cause idref="T34" />
<clue><clueLoc>In Jurkat cells</clueLoc>, <corefCause>both sites</corefCause> were <clueType>required</clueType> <linkTheme>for</linkTheme> maximal IL-2Rbeta promoter activity, and in HeLaS3 cells, transfection of Egr-1 could drive activity of a reporter construct containing both sites.</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="A13" />
<cause idref="T39" />
<clue><clueLoc>In Jurkat cells</clueLoc>, <corefCause>both sites</corefCause> were <clueType>required</clueType> <linkTheme>for</linkTheme> maximal IL-2Rbeta promoter activity, and in HeLaS3 cells, transfection of Egr-1 could drive activity of a reporter construct containing both sites.</clue>
</event>
<event id="E6">
<type class="Artificial_process" />
<theme idref="T43" />
<theme idref="A14" />
<clue>In Jurkat cells, both sites were required for maximal IL-2Rbeta promoter activity, and in HeLaS3 cells, <clueType>transfection</clueType> <linkTheme>of</linkTheme> Egr-1 could drive activity of a reporter construct containing both sites.</clue>
</event>
<event id="E250">
<type class="Gene_expression" />
<theme idref="T43" />
<clue>In Jurkat cells, both sites were required for maximal IL-2Rbeta promoter activity, and <clueLoc>in HeLaS3 cells</clueLoc>, <clueType>transfection</clueType> <linkTheme>of</linkTheme> Egr-1 could drive activity of a reporter construct containing both sites.</clue>
</event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="E250" />
<cause idref="E6" />
<clue>In Jurkat cells, both sites were required for maximal IL-2Rbeta promoter activity, and <clueLoc>in HeLaS3 cells</clueLoc>, <clueType>transfection</clueType> of Egr-1 could drive activity of a reporter construct containing both sites.</clue>
</event>
<event id="E26">
<type class="Positive_regulation" />
<theme idref="A15" />
<cause idref="E25" />
<clue>In Jurkat cells, both sites were required for maximal IL-2Rbeta promoter activity, and <clueLoc>in HeLaS3 cells</clueLoc>, transfection of Egr-1 could <clueType>drive</clueType> activity of a reporter construct containing both sites.</clue>
</event>
<sentence id="S11">Moreover, <term sem="Protein_molecule" id="T44" lex="Sp1">Sp1</term> and <term sem="Protein_molecule" id="T45" lex="Egr-1">Egr-1</term> could form a complex with kinetics that correlated with the production of <term sem="Protein_molecule" id="T46" lex="Egr-1">Egr-1</term> in <term sem="Cell_cultured" id="T47" lex="Jurkat_cell">Jurkat cells</term> upon <term sem="Organic_compound_other" id="T48" lex="PMA">PMA</term> stimulation.</sentence>
<event id="E27">
<type class="Binding" />
<theme idref="T44" />
<theme idref="T45" />
<clue>Moreover, Sp1 and Egr-1 could <clueType>form a complex</clueType> with kinetics that correlated with the production of Egr-1 in Jurkat cells upon PMA stimulation.</clue>
</event>
<event id="E28">
<type class="Gene_expression" />
<theme idref="T46" />
<clue>Moreover, Sp1 and Egr-1 could form a complex with kinetics that correlated with the <clueType>production</clueType> <linkTheme>of</linkTheme> Egr-1 <clueLoc>in Jurkat cells upon PMA stimulation</clueLoc>.</clue>
</event>
<event id="E29">
<type class="Correlation" />
<theme idref="E27" />
<theme idref="E28" />
<clue>Moreover, Sp1 and Egr-1 could form a complex with kinetics that <clueType>correlated</clueType> <linkTheme>with</linkTheme> the production of Egr-1 <clueLoc>in Jurkat cells upon PMA stimulation</clueLoc>.</clue>
</event>
<event id="E30">
<type class="Physiological_process" />
<theme idref="T47" />
<cause idref="T48" />
<clue>Moreover, Sp1 and Egr-1 could form a complex with kinetics that correlated with the production of Egr-1 in Jurkat cells <linkCause>upon</linkCause> PMA <clueType>stimulation</clueType>.</clue>
</event>
<sentence id="S12">Thus, <term sem="Protein_molecule" id="T49" lex="Sp1">Sp1</term> and <term sem="Protein_molecule" id="T50" lex="Egr-1">Egr-1</term> physically and functionally cooperate to mediate maximal <term sem="Other" id="T51" lex="IL-2Rbeta_promoter_activity"><term sem="DNA_domain_or_region" id="T52" lex="IL-2Rbeta_promoter">IL-2Rbeta promoter</term> activity</term>.</sentence>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="T52" />
<cause idref="T49" />
<cause idref="T50" />
<clue>Thus, Sp1 and Egr-1 physically and functionally <clueType>cooperate to mediate</clueType> maximal IL-2Rbeta promoter activity.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
